Recent stock performance of Centene Corp (CNC, Financial) shows a daily loss of 3.49%, with a three-month decline of 7.05%. Despite these figures, the company's Earnings Per Share (EPS) stands at 5.03. This leads to the pressing question: is Centene modestly undervalued? The following analysis delves into the valuation of Centene, encouraging investors to explore the intricacies of its market position and financial health.
Company Overview
Centene is a pivotal player in the healthcare sector, primarily focusing on government-sponsored healthcare plans. With a market cap of $39.80 billion and sales reaching $155.50 billion, Centene operates with a modest operating margin of 2.15%. As of June 2023, it served 24 million medical members, predominantly in Medicaid, individual exchanges, and Medicare Advantage plans. The company's stock is currently priced at $74.63, against a GF Value of $91.01, suggesting that Centene might be trading below its fair value.
Understanding GF Value
The GF Value is a proprietary measure designed to determine a stock's intrinsic value based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates. For Centene, this value is set at $91.01, which is significantly higher than its current trading price. This discrepancy indicates that Centene is potentially undervalued, suggesting a possible investment opportunity with promising returns for the future.
Financial Strength and Stability
Investing in companies with robust financial health is crucial. Centene's financial strength is rated 7 out of 10 by GuruFocus, indicating a fair condition. The company's cash-to-debt ratio stands at 1.09, which, although lower than 61.9% of its industry peers, still supports a stable financial structure. This assessment is vital for investors considering long-term investments in the healthcare sector.
Profitability and Growth Prospects
Centene has demonstrated consistent profitability over the past decade, with a strong profitability rank of 8 out of 10. Despite a competitive operating margin, the company's revenue and EBITDA growth rates are commendable. Such financial metrics are crucial for assessing the company's ability to sustain and expand its operations effectively.
Value Creation Analysis: ROIC vs. WACC
An essential aspect of evaluating a company's profitability is comparing its Return on Invested Capital (ROIC) against the Weighted Average Cost of Capital (WACC). Centene's ROIC is currently at 3.81, below its WACC of 6.53, which suggests challenges in generating value over its capital cost. However, this metric should be monitored for future improvements as it is crucial for long-term value creation.
Conclusion
Considering the modest undervaluation of Centene (CNC, Financial), combined with its strong profitability and fair financial health, the stock presents a potentially lucrative opportunity for value investors. For more detailed financials of Centene, interested parties can visit Centene's 30-Year Financials.
To discover other high-quality companies that may deliver above-average returns, please check out the GuruFocus High Quality Low Capex Screener.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
